MedPath

Integrated Supportive and Palliative Care for Older Adults in the ICU

Not Applicable
Recruiting
Conditions
Critical Illness
Interventions
Behavioral: Early Integration of Specialty Palliative Care with Critical Care
Registration Number
NCT04921631
Lead Sponsor
University of Pittsburgh
Brief Summary

The National Academy of Medicine and the National Institutes of Health have called for urgent action to improve the care delivered to the nearly 1,000,000 older Americans who die in intensive care units (ICUs) annually, or survive with substantial impairments. These patients often die with distressing symptoms and may receive more invasive, life-prolonging treatment than they would choose for themselves. Moreover, their family members acting as surrogate decision makers often experience lasting psychological distress from the ICU experience. The investigators will conduct a randomized trial among 500 patients and 750 surrogates and up to 150 clinicians to determine whether early integration of specialty palliative care with standard critical care can improve outcomes for critically ill older patients at high risk of death or severe functional impairments and their family members.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionEarly Integration of Specialty Palliative Care with Critical CareThe intervention arm will receive early specialty palliative care integrated with standard critical care.
Primary Outcome Measures
NameTimeMethod
Patient and family centeredness of careMeasured at 3 months after hospital discharge

12-item Patient Perceived Patient-Centeredness of Care Scale (PPPC), previously modified for use by surrogates, completed at 3-month telephone follow-up of surrogates.

Secondary Outcome Measures
NameTimeMethod
Unmet palliative care needsMeasured at day 5 post-randomization

Measured using the adapted Needs of Social Nature, Existential Concerns, Symptoms, and Therapeutic Interaction (NEST) scale administered to surrogates and patients (if able) on day 5 post-randomization. The adapted NEST scale is designed for ICU use; it is a 13-item instrument developed to identify unmet social, emotional, physical, and care-system needs in serious illness.

Surrogates' clarity about patient values and preferencesMeasured on study day 5

Assessed by surrogates/patients after family meetings on study day 5 using the "informed" and "values clarity" subscales, 6 items out of the 16-item Decisional Conflict Scale (DCS). The scale has established responsiveness to change, test-retest reliability (r=0.81), internal consistency (α=0.92), and discriminant validity.

Duration of mechanical ventilationMeasured at 6 months

Duration of time patient spent on mechanical ventilation during index hospitalization

Composite measure of goal-concordant careMeasured at 3 months

Assessed by surrogates and patients (if able) at 3-month telephone follow-up using an 8-item composite measure of goal-concordant care.

Satisfaction with ICU careMeasured at 3 months

Assessed using the Family Satisfaction in the ICU (FS-ICU) instrument at 3-month telephone follow-up of surrogates and patients (if able). The FS-ICU is a 24-item scale concerning satisfaction with care, communication, and decision-making in the ICU.

Risk of post-traumatic stress disorderMeasured at 6 months

Assessed using the Impact of Events Scale-revised (IES-R) at 6-month telephone follow-up of surrogates and patients (if able). The IES-R is a valid, reliable, and responsive 22-item instrument measuring symptoms of avoidance and intrusive thoughts. A score ≥33 indicates a high risk of PTSD. It has been used successfully among ICU surrogates.

Proportion of patients who received comfort-focused care during the index hospitalization and time to comfort-focused care during index hospitalizationMeasured at 6 months

Proportion of patients who received comfort-focused care during the index hospitalization and time to comfort-focused care during index hospitalization

Surrogates' prognostic awarenessMeasured on study day 5

Assessed on study day 5 using the validated Clinician-Surrogate Concordance Scale (CSCS), which our research team developed. The single item CSCS has excellent test-retest reliability (r =0.91). It has established criterion validity and responsiveness to change.

Symptoms of anxiety and depressionMeasured at 6 months

The Hospital Anxiety and Depression Scale (HADS) is a 14-item, two-domain (anxiety, depression) instrument with established reliability and validity among ICU surrogates that is recommended by consensus guidelines for use among ICU surrogates. Assessed at 6-month telephone follow-up of surrogates and patients (if able).

Cost of index hospitalizationMeasured at 6 months

Assigning costs using validated methods, the cost of index hospitalization will be calculated

Proportion of patients with new DNR order during index hospitalization and time to first DNR order during index hospitalizationMeasured at 6 months

Proportion of patients with new DNR order during index hospitalization and time to first DNR order during index hospitalization

Proportion of patients enrolled in hospice during index hospitalization and time to hospice enrollment during index hospitalizationMeasured at 6 months

Proportion of patients enrolled in hospice during index hospitalization and time to hospice enrollment during index hospitalization

ICU and hospital length of stayMeasured at 6 months

Duration of time patient spent in ICU and hospital during index hospitalization

Resource utilization over 6-months follow-upMeasured at 3 months and 6 months

Among hospital survivors investigators will perform interviews with surrogates at 3-months and 6-months to identify patient's post-discharge healthcare utilization (e.g. hospital admissions, ED visits, skilled-nursing facility use, hospice use, etc.), assigning costs using validated methods.

Trial Locations

Locations (1)

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath